Vaxart Payables Turnover from 2010 to 2025

VXRT Stock  USD 0.48  0  0.40%   
Vaxart Payables Turnover yearly trend continues to be comparatively stable with very little volatility. Payables Turnover is likely to outpace its year average in 2025. Payables Turnover is a liquidity ratio that shows how quickly Vaxart Inc pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
49.47
Current Value
51.95
Quarterly Volatility
16.72685227
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.3 M, Interest Expense of 1.9 M or Total Revenue of 27.3 M, as well as many indicators such as Price To Sales Ratio of 47.78, Dividend Yield of 0.0 or PTB Ratio of 23.85. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Vaxart Inc over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Vaxart's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Slightly volatile
   Payables Turnover   
       Timeline  

Vaxart Payables Turnover Regression Statistics

Arithmetic Mean16.62
Geometric Mean7.38
Coefficient Of Variation100.67
Mean Deviation12.25
Median12.59
Standard Deviation16.73
Sample Variance279.79
Range51.9244
R-Value0.67
Mean Square Error165.37
R-Squared0.45
Significance0
Slope2.35
Total Sum of Squares4,197

Vaxart Payables Turnover History

2025 51.95
2024 49.47
2023 43.02
2022 0.59
2021 12.59
2020 9.31
2019 17.07

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Payables Turnover, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Payables Turnover 49.47  51.95 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.